Please Wait.....
Report
Europe Musculoskeletal (MSK) Disease Management Market - Industry Trends Forecast to 2030
Market Report I 2022-11-01 I 492 Pages I Data Bridge Market Research
Europe musculoskeletal (MSK) disease management market is projected to register a CAGR of 22.2% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030
Market Segmentation
Europe Musculoskeletal (MSK) Disease Management Market, By Type (Digital Biofeedback System, Musculoskeletal-focused Digital Apps (MDAs), Solutions, and Others), Technology (Precision Motion Technology, Computer Vision Technology, and Other Technologies), Integration Type (Phone, Tablet, Computer, and Others), Modality (Virtual Therapy, In-Person Therapy, Customized/Personalized Therapy, and Others), Application (Pre-Surgery Applications and Post-Surgery Applications), Patient Population (Pediatrics, Adults, and Geriatrics), End User (Hospitals & Clinics, Nursing Homes, Health Centers, Rehabilitation Centres, Virtual/Home Health Care Settings, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, and Rest of Europe) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Europe musculoskeletal (MSK) disease management market are:
- Rising awareness about Musculoskeletal (MSK) diseases
- Increasing cases of bone fracture
Market Players
The key market players operating in the Europe musculoskeletal (MSK) disease management market are listed below:
- Hinge Health, Inc.
- Omada Health Inc.
- RecoveryOne
- Sword Health, Inc.
- IncludeHealth
- kaia health
- Wellness Coaches USA, LLC
- Kiio
- DarioHealth Corp.
- IMC.
- Sparta Science
- Phzio.
- Airrosti Rehab Center, LLC
- SPRITE HEALTH
- Limber Health, Inc.
TABLE OF CONTENTS
1 INTRODUCTION 93
1.1 OBJECTIVES OF THE STUDY 93
1.2 MARKET DEFINITION 93
1.3 OVERVIEW OF THE EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET 93
1.4 CURRENCY AND PRICING 96
1.5 LIMITATION 96
1.6 MARKETS COVERED 97
2 MARKET SEGMENTATION 104
2.1 MARKETS COVERED 104
2.2 GEOGRAPHIC SCOPE 105
2.3 YEARS CONSIDERED FOR THE STUDY 106
2.4 CURRENCY AND PRICING 106
2.5 RESEARCH METHODOLOGY 107
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 110
2.7 MULTIVARIATE MODELLING 111
2.8 TYPE SEGMENT LIFELINE CURVE 111
2.9 DBMR MARKET POSITION GRID 112
2.10 VENDOR SHARE ANALYSIS 114
2.11 MARKET APPLICATION COVERAGE GRID 115
2.12 THE CATEGORY VS TIME GRID 116
2.13 SECONDARY SOURCES 117
2.14 ASSUMPTIONS 117
3 EXECUTIVE SUMMARY 118
4 PREMIUM INSIGHTS 121
4.1 PESTEL ANALYSIS 122
4.2 PORTER'S FIVE FORCE 123
4.3 KEY STRATEGIC INITIATIVES 124
4.4 EMERGING TREND ANALYSIS OF DIGITAL REHABILITATION AND DIGITAL PHYSIOTHERAPY IN THE EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET 126
4.4.1 DIGITAL REHABILITATION 126
4.4.2 DIGITAL PHYSIOTHERAPY 126
5 EPIDEMOLOGY 128
5.1 US 129
5.2 CANADA 130
5.3 MEXICO 130
5.4 GERMANY 131
5.5 FRANCE 132
5.6 U.K. 133
5.7 ITALY 134
5.8 SPAIN 135
5.9 RUSSIA 136
5.10 TURKEY 137
5.11 BELGIUM 138
5.12 DENMARK 139
5.13 NETHERLANDS 140
5.14 SWITZERLAND 141
5.15 SWEDEN 142
5.16 POLAND 143
5.17 NORWAY 144
5.18 FINLAND 145
5.19 CHINA 146
5.20 JAPAN 147
5.21 SOUTH KOREA 148
5.22 INDIA 149
5.23 AUSTRALIA 150
5.24 NEW ZEALAND 151
5.25 SINGAPORE 152
5.26 THAILAND 153
5.27 MALAYSIA 154
5.28 VIETNAM 155
5.29 TAIWAN 156
5.30 INDONESIA 157
5.31 PHILIPPINES 158
5.32 BRAZIL 159
5.33 ARGENTINA 160
5.34 SOUTH AFRICA 161
5.35 SAUDI ARABIA 162
5.36 BAHRAIN 163
5.37 U.A.E 164
5.38 KUWAIT 165
5.39 OMAN 166
5.40 QATAR 167
5.41 EGYPT 168
5.42 ISRAEL 169
6 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: REGULATIONS 181
7 MARKET OVERVIEW 188
7.1 DRIVERS 190
7.1.1 TECHNOLOGICAL ADVANCES IN THE DIAGNOSIS OF MUSCULOSKELETAL DISORDERS (MSDS) 190
7.1.2 RISING AWARENESS ABOUT MUSCULOSKELETAL DISORDERS (MSDS) 190
7.1.3 GROWING PREVALENCE OF RHEUMATOID ARTHRITIS (RA) 191
7.1.4 INCREASING CASES OF BONE FRACTURES 191
7.2 RESTRAINTS 192
7.2.1 HIGH COST OF DIAGNOSIS AND TREATMENT OF ORTHOPEDIC DISEASES 192
7.2.2 RISE IN USE OF HEAVY-DUTY DRUGS IN TREATING MUSCULOSKELETAL (MSK) PAIN 193
7.3 OPPORTUNITIES 193
7.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 193
7.3.2 USE OF TELEMEDICINE IN MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT 194
7.3.3 INCREASED USE OF MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) FOR MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT 195
7.3.4 USE OF HOME HEALTHCARE FOR MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT 195
7.4 CHALLENGES 196
7.4.1 CHALLENGES FACED BY PHYSICIANS WHILE TREATING ATHLETES WITH MUSCULOSKELETAL (MSK) DISEASES 196
7.4.2 STRICT REGULATORY GUIDELINES FOR MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT 196
8 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TYPE 198
8.1 OVERVIEW 199
8.2 DIGITAL BIOFEEDBACK SYSTEM 203
8.3 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) 204
8.3.1 IOS-SYSTEMS 205
8.3.2 ANDROID-SYSTEMS 205
8.3.3 OTHER SYSTEMS 205
8.4 SOLUTIONS 205
8.4.1 DIRECT SUPPORT 207
8.4.1.1 MULTIMODAL PAIN THERAPY 208
8.4.1.2 ONSITE PERSONALIZED THERAPY 208
8.4.1.3 SOLUTIONS TO REDUCE INJURIES 208
8.4.1.4 MIND-BODY CONNECTION IMPROVEMENT 208
8.4.1.5 EARLY PREVENTION AND INTERVENTION 208
8.4.1.6 PREVENTION, RECOVERY AND EDUCATION 208
8.4.1.7 PERSONALIZED PAIN RECOVERY 208
8.4.1.8 SENSOR-GUIDED EXERCISE THERAPY 208
8.4.1.9 TRAINING OF EDUCATION SKILLS 208
8.4.1.10 SELF-TRACKING OF PAIN EPISODES 208
8.4.1.11 RELAXATION TECHNIQUES 209
8.4.1.12 POST-OPERATIVE PAIN TRACKING 209
8.4.1.12.1 REAL-TIME MONITORING 209
8.4.1.12.2 SYMPTOM MANAGEMENT 209
8.4.1.13 OTHERS 209
8.4.2 PROGRESS TRACKING 209
8.4.3 OTHERS 209
8.5 OTHERS 210
9 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY TECHNOLOGY 211
9.1 OVERVIEW 212
9.2 PRECISION MOTION TECHNOLOGY 216
9.3 COMPUTER MOTION TECHNOLOGY 216
9.4 OTHER TECHNOLOGIES 217
10 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY INTEGRATION TYPE 218
10.1 OVERVIEW 219
10.2 PHONE 223
10.2.1 DIGITAL BIOFEEDBACK SYSTEM 224
10.2.2 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) 224
10.2.3 THERAPIES 224
10.2.4 OTHERS 224
10.3 TABLET 224
10.3.1 DIGITAL BIOFEEDBACK SYSTEM 226
10.3.2 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) 226
10.3.3 THERAPIES 226
10.3.4 OTHERS 226
10.4 COMPUTER 226
10.4.1 DIGITAL BIOFEEDBACK SYSTEM 227
10.4.2 MUSCULOSKELETAL-FOCUSED DIGITAL APPS (MDAS) 227
10.4.3 THERAPIES 227
10.4.4 OTHERS 227
10.5 OTHERS 228
11 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY MODALITY 229
11.1 OVERVIEW 230
11.2 VIRTUAL THERAPY 234
11.2.1 INTERNET BASED 235
11.2.2 TELEPHONE BASED 236
11.2.3 MOBILE PHONE APPLICATION 236
11.2.4 INTERNET BASED WITH TELEPHONE SUPPORT 236
11.2.5 INTERACTIVE VOICE RESPONSE 236
11.2.6 VIDEO TELECONFERENCING 236
11.2.7 MOBILE PHONE APPLICATION WITH TELEPHONE SUPPORT 236
11.2.8 INTERACTIVE VOICE RESPONSE WITH TELEPHONE SUPPORT 236
11.2.9 INTERNET BASED WITH VIDEO CONFERENCING 236
11.2.10 INTERACTIVE VOICE RESPONSE WITH TELEPHONE SUPPORT AND INTERNET BASED 236
11.2.11 OTHERS 237
11.3 IN-PERSON THERAPY 237
11.4 CUSTOMIZED/ PERSONALIZED THERAPY 238
11.5 OTHERS 239
12 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY APPLICATION 240
12.1 OVERVIEW 241
12.2 PRE-SURGERY APPLICATION 245
12.2.1 ANTERIOR CERVICAL DISCECTOMY AND FUSION SURGERY 246
12.2.2 ANTERIOR LUMBAR INTERBODY FUSION SURGERY 246
12.2.3 LATERAL LUMBAR INTERBODY FUSION SURGERY 246
12.2.4 INTERNET BASED WITH TELEPHONE SUPPORT 246
12.2.5 MINIMALLY INVASIVE SPINE SURGERY 247
12.2.6 MOTION PRESERVING SPINE SURGERY 247
12.2.7 POSTERIOR CERVICAL FUSION SURGERY 247
12.2.8 POSTERIOR LUMBAR INTERBODY FUSION SURGERY 247
12.2.9 SACROILIAC JOINT FUSION SURGERY 247
12.2.10 SCOLIOSIS CORRECTION SURGERY 247
12.2.11 VERTEBRAL AUGMENTATION SURGERY 247
12.2.12 FRACTURE FIXATION SURGERY 247
12.2.13 HIP SURGERY 247
12.2.13.1 TOTAL HIP REPLACEMENT 248
12.2.13.2 PARTIAL HIP REPLACEMENT 248
12.2.13.3 HIP RESURFACING 248
12.2.13.4 OTHERS 248
12.2.14 KNEE SURGERY 248
12.2.14.1 TOTAL KNEE REPLACEMENT 249
12.2.14.2 PARTIAL KNEE REPLACEMENT 249
12.2.14.3 MISS FUSION 249
12.2.14.4 OTHERS 249
12.3 POST-SURGERY APPLICATION 249
12.3.1 ANTERIOR CERVICAL DISCECTOMY AND FUSION SURGERY 251
12.3.2 ANTERIOR LUMBAR INTERBODY FUSION SURGERY 251
12.3.3 LATERAL LUMBAR INTERBODY FUSION SURGERY 251
12.3.4 INTERNET BASED WITH TELEPHONE SUPPORT 251
12.3.5 MINIMALLY INVASIVE SPINE SURGERY 251
12.3.6 MOTION PRESERVING SPINE SURGERY 251
12.3.7 POSTERIOR CERVICAL FUSION SURGERY 251
12.3.8 POSTERIOR LUMBAR INTERBODY FUSION SURGERY 251
12.3.9 SACROILIAC JOINT FUSION SURGERY 251
12.3.10 SCOLIOSIS CORRECTION SURGERY 251
12.3.11 VERTEBRAL AUGMENTATION SURGERY 252
12.3.12 FRACTURE FIXATION SURGERY 252
12.3.13 HIP SURGERY 252
12.3.13.1 TOTAL HIP REPLACEMENT 252
12.3.13.2 PARTIAL HIP REPLACEMENT 252
12.3.13.3 HIP RESURFACING 252
12.3.13.4 OTHERS 253
12.3.14 KNEE SURGERY 253
12.3.14.1 TOTAL KNEE REPLACEMENT 253
12.3.14.2 PARTIAL KNEE REPLACEMENT 253
12.3.14.3 MISS FUSION 253
12.3.14.4 OTHERS 253
13 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY PATIENT POPULATION 254
13.1 OVERVIEW 255
13.2 PEDIATRICS 259
13.2.1 MALE 259
13.2.2 FEMALE 259
13.3 ADULTS 260
13.3.1 MALE 260
13.3.2 FEMALE 260
13.4 GERIATRIC 261
13.4.1 MALE 261
13.4.2 FEMALE 261
14 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY END USER 262
14.1 OVERVIEW 263
14.2 HOSPITALS & CLINICS 266
14.2.1 MULTIPLE 267
14.2.2 PHYSICAL THERAPIST 267
14.2.3 NURSE 267
14.2.4 HEALTH COACH 267
14.2.5 OTHERS 267
14.3 NURSING HOMES 267
14.3.1 MULTIPLE 269
14.3.2 PHYSICAL THERAPIST 269
14.3.3 NURSE 269
14.3.4 HEALTH COACH 269
14.3.5 OTHERS 269
14.4 HEALTH CENTERS 269
14.4.1 MULTIPLE 270
14.4.2 PHYSICAL THERAPIST 270
14.4.3 NURSE 270
14.4.4 HEALTH COACH 271
14.4.5 OTHERS 271
14.5 REHABILITATION CENTERS 271
14.5.1 MULTIPLE 272
14.5.2 PHYSICAL THERAPIST 272
14.5.3 NURSE 272
14.5.4 HEALTH COACH 272
14.5.5 OTHERS 272
14.6 VIRTUAL/HOME HEALTH CARE SETTINGS 272
14.6.1 MULTIPLE 274
14.6.2 PHYSICAL THERAPIST 274
14.6.3 NURSE 274
14.6.4 HEALTH COACH 274
14.6.5 OTHERS 274
14.7 OTHERS 274
15 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET, BY REGION 276
15.1 EUROPE 277
15.1.1 GERMANY 295
15.1.2 FRANCE 306
15.1.3 U.K. 317
15.1.4 ITALY 328
15.1.5 SPAIN 339
15.1.6 RUSSIA 350
15.1.7 TURKEY 361
15.1.8 BELGIUM 372
15.1.9 DENMARK 383
15.1.10 NETHERLANDS 394
15.1.11 SWITZERLAND 405
15.1.12 SWEDEN 416
15.1.13 POLAND 427
15.1.14 NORWAY 438
15.1.15 FINLAND 449
15.1.16 REST OF EUROPE 460
16 EUROPE MUSCULOSKELETAL (MSK) DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE 461
16.1 COMPANY SHARE ANALYSIS: EUROPE 461
17 SWOT ANALYSIS 462
18 COMPANY PROFILE 463
18.1 HINGE HEALTH, INC 463
18.1.1 COMPANY SNAPSHOT 463
18.1.2 COMPANY SHARE ANALYSIS 463
18.1.3 PRODUCT PORTFOLIO 464
18.1.4 RECENT DEVELOPMENTS 464
18.2 SWORD HEALTH, INC 465
18.2.1 COMPANY SNAPSHOT 465
18.2.2 COMPANY SHARE ANALYSIS 465
18.2.3 PRODUCT PORTFOLIO 465
18.2.4 RECENT DEVELOPMENT 466
18.3 OMADA HEALTHA INC. 467
18.3.1 COMPANY SNAPSHOT 467
18.3.2 COMPANY SHARE ANALYSIS 467
18.3.3 PRODUCT PORTFOLIO 467
18.3.4 RECENT DEVELOPMENT 468
18.4 KAIA HEALTH 469
18.4.1 COMPANY SNAPSHOT 469
18.4.2 COMPANY SHARE ANALYSIS 469
18.4.3 PRODUCT PORTFOLIO 469
18.4.4 RECENT DEVELOPMENTS 470
18.5 WELLNESS COACHES USA, LLC. 471
18.5.1 COMPANY SNAPSHOT 471
18.5.2 COMPANY SHARE ANALYSIS 471
18.5.3 PRODUCT PORTFOLIO 471
18.5.4 RECENT DEVELOPMENT 472
18.6 AIRROSTI REHAB CENTER, LLC 473
18.6.1 COMPANY SNAPSHOT 473
18.6.2 PRODUCT PORTFOLIO 473
18.6.3 RECENT DEVELOPMENTS 474
18.7 DARIOHEALTH CORP.(2021) 475
18.7.1 COMPANY SNAPSHOT 475
18.7.2 REVENUE ANALYSIS 475
18.7.3 PRODUCT PORTFOLIO 476
18.7.4 RECENT DEVELOPMENTS 476
18.8 INCLUDEHEALTH (2021) 477
18.8.1 COMPANY SNAPSHOT 477
18.8.2 PRODUCT PORTFOLIO 477
18.8.3 RECENT DEVELOPMENTS 477
18.9 IMC (2021) 478
18.9.1 COMPANY SNAPSHOT 478
18.9.2 PRODUCT PORTFOLIO 478
18.9.3 RECENT DEVELOPMENT 478
18.10 KIIO 479
18.10.1 COMPANY SNAPSHOT 479
18.10.2 PRODUCT PORTFOLIO 479
18.10.3 RECENT DEVELOPMENT 480
18.11 LIMBER HEALTH, INC. 481
18.11.1 COMPANY SNAPSHOT 481
18.11.2 PRODUCT PORTFOLIO 481
18.11.3 RECENT DEVELOPMENT 481
18.12 MOVEMENT RX (2021) 482
18.12.1 COMPANY SNAPSHOT 482
18.12.2 PRODUCT PORTFOLIO 482
18.12.3 RECENT DEVELOPMENT 482
18.13 PHZIO (2021) 483
18.13.1 COMPANY SNAPSHOT 483
18.13.2 PRODUCT PORTFOLIO 483
18.13.3 RECENT DEVELOPMENT 483
18.14 RECOVERYONE 484
18.14.1 COMPANY SNAPSHOT 484
18.14.2 PRODUCT PORTFOLIO 484
18.14.3 RECENT DEVELOPMENT 484
18.15 SPARTA SCIENCE 485
18.15.1 COMPANY SNAPSHOT 485
18.15.2 PRODUCT PORTFOLIO 485
18.15.3 RECENT DEVELOPMENTS 486
18.16 SPRITE HEALTH 487
18.16.1 COMPANY SNAPSHOT 487
18.16.2 PRODUCT PORTFOLIO 487
18.16.3 RECENT DEVELOPMENTS 487
18.17 SIMPLETHERAPY, INC. 488
18.17.1 COMPANY SNAPSHOT 488
18.17.2 PRODUCT PORTFOLIO 488
18.17.3 RECENT DEVELOPMENT 488
19 QUESTIONNAIRE 489
20 RELATED REPORTS 492
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security